Investigative Ophthalmology & Visual Science, Vol 34, 3601-3608, Copyright © 1993 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Thrombospondin and in vivo angiogenesis induced by basic fibroblast growth factor or lipopolysaccharide

D BenEzra, BW Griffin, G Maftzir and O Aharonov
Immuno Ophthalmology Unit, Hadassah University Hospital, Jerusalem, Israel.

PURPOSE. To reexamine the possible effect of human thrombospondin on in vivo angiogenesis. METHODS. In vivo angiogenesis in the rabbit cornea was induced by implants of Elvax-40 sequestering human recombinant basic fibroblast growth factor (bFGF) or bacterial endotoxin lipopolysaccharide (LPS). Implants sequestering various concentrations of thrombospondin were examined for their ability to induce angiogenesis and also for their possible influence on the angiogenic potential of bFGF- or LPS-sequestering implants. RESULTS. Constant and reproducible angiogenic stimuli were obtained with implants sequestering 250 ng or more of bFGF or 100 ng or more of LPS. Implants sequestering 500 ng of thrombospondin induce very little clinical change but larger concentrations induce infiltration of leukocytes and a mild angiogenic stimulus. Combination of thrombospondin implants with bFGF or LPS implants enhanced the angiogenic response to either of these factors. The thrombospondin enhancing effect was more prominent when LPS was the stimulating factor. Histologic examination of the tested corneas disclosed that the LPS angiogenic stimulus follows the influx of leukocytes. Conversely, the bFGF angiogenic stimulus appears to be associated with the proliferation of stromal keratocytes and corneal epithelial cells. The thrombospondin angiogenic enhancing effect on both the LPS and bFGF stimuli was correlated with an increased infiltration of polymorphonuclear cells. CONCLUSION. In this system, thrombospondin enhanced the in vivo angiogenic process induced by bFGF or LPS. This enhancement appears to be associated with an in vivo activation and chemotactic effect on the polymorphonuclear cells.

This article has been cited by other articles:

				C. Cursiefen, S. Masli, T. F. Ng, M. R. Dana, P. Bornstein, J. Lawler, and J. W. Streilein Roles of Thrombospondin-1 and -2 in Regulating Corneal and Iris Angiogenesis Invest. Ophthalmol. Vis. Sci., April 1, 2004; 45(4): 1117 - 1124. [Abstract] [Full Text] [PDF]

				M. J. Calzada, L. Zhou, J. M. Sipes, J. Zhang, H. C. Krutzsch, M. L. Iruela-Arispe, D. S. Annis, D. F. Mosher, and D. D. Roberts {alpha}4{beta}1 Integrin Mediates Selective Endothelial Cell Responses to Thrombospondins 1 and 2 In Vitro and Modulates Angiogenesis In Vivo Circ. Res., March 5, 2004; 94(4): 462 - 470. [Abstract] [Full Text] [PDF]

				R. Dardik, A. Solomon, J. Loscalzo, R. Eskaraev, A. Bialik, I. Goldberg, G. Schiby, and A. Inbal Novel Proangiogenic Effect of Factor XIII Associated With Suppression of Thrombospondin 1 Expression Arterioscler. Thromb. Vasc. Biol., August 1, 2003; 23(8): 1472 - 1477. [Abstract] [Full Text] [PDF]

				I. Sargiannidou, J. Zhou, and G. P. Tuszynski The Role of Thrombospondin-1 in Tumor Progression Experimental Biology and Medicine, September 1, 2001; 226(8): 726 - 733. [Abstract] [Full Text] [PDF]

				K. Mori, A. Ando, P. Gehlbach, D. Nesbitt, K. Takahashi, D. Goldsteen, M. Penn, C. T. Chen, K. Mori, M. Melia, et al. Inhibition of Choroidal Neovascularization by Intravenous Injection of Adenoviral Vectors Expressing Secretable Endostatin Am. J. Pathol., July 1, 2001; 159(1): 313 - 320. [Abstract] [Full Text] [PDF]

				L. Chandrasekaran, C.-Z. He, H. Al-Barazi, H. C. Krutzsch, M. L. Iruela-Arispe, and D. D. Roberts Cell Contact-dependent Activation of alpha 3beta 1 Integrin Modulates Endothelial Cell Responses to Thrombospondin-1 Mol. Biol. Cell, September 1, 2000; 11(9): 2885 - 2900. [Abstract] [Full Text]

				A. Shafiee, J. S. Penn, H. C. Krutzsch, J. K. Inman, D. D. Roberts, and D. A. Blake Inhibition of Retinal Angiogenesis by Peptides Derived from Thrombospondin-1 Invest. Ophthalmol. Vis. Sci., July 1, 2000; 41(8): 2378 - 2388. [Abstract] [Full Text]

				H. Miyajima–Uchida, H. Hayashi, R. Beppu, M. Kuroki, M. Fukami, F. Arakawa, Y. Tomita, M. Kuroki, and K. Oshima Production and Accumulation of Thrombospondin-1 in Human Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., February 1, 2000; 41(2): 561 - 567. [Abstract] [Full Text]

				A. Canfield and A. Schor Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells J. Cell Sci., January 2, 1995; 108(2): 797 - 809. [Abstract] [PDF]

				R. G. Rodrigues, N.-h. Guo, L. Zhou, J. M. Sipes, S. B. Williams, N. S. Templeton, H. R. Gralnick, and D. D. Roberts Conformational Regulation of the Fibronectin Binding and alpha 3beta 1 Integrin-mediated Adhesive Activities of Thrombospondin-1 J. Biol. Chem., July 20, 2001; 276(30): 27913 - 27922. [Abstract] [Full Text] [PDF]